APA

Qin J., Liu J., Wu C., Xu J., Tang B., Guo K., Chen X., Liu W., Wu T., Zhou H., Fang M. & Wu Z. (20201215). Synthesis and biological evaluation of (3/4-(pyrimidin-2-ylamino)benzoyl)-based hydrazine-1-carboxamide/carbothioamide derivatives as novel RXRα antagonists. : Journal of enzyme inhibition and medicinal chemistry.

Chicago

Qin Jingbo, Liu Jie, Wu Chunxiao, Xu Jianwen, Tang Bowen, Guo Kaiqiang, Chen Xiaohui, Liu Weihao, Wu Tong, Zhou Hu, Fang Meijuan and Wu Zhen. 20201215. Synthesis and biological evaluation of (3/4-(pyrimidin-2-ylamino)benzoyl)-based hydrazine-1-carboxamide/carbothioamide derivatives as novel RXRα antagonists. : Journal of enzyme inhibition and medicinal chemistry.

Harvard

Qin J., Liu J., Wu C., Xu J., Tang B., Guo K., Chen X., Liu W., Wu T., Zhou H., Fang M. and Wu Z. (20201215). Synthesis and biological evaluation of (3/4-(pyrimidin-2-ylamino)benzoyl)-based hydrazine-1-carboxamide/carbothioamide derivatives as novel RXRα antagonists. : Journal of enzyme inhibition and medicinal chemistry.

MLA

Qin Jingbo, Liu Jie, Wu Chunxiao, Xu Jianwen, Tang Bowen, Guo Kaiqiang, Chen Xiaohui, Liu Weihao, Wu Tong, Zhou Hu, Fang Meijuan and Wu Zhen. Synthesis and biological evaluation of (3/4-(pyrimidin-2-ylamino)benzoyl)-based hydrazine-1-carboxamide/carbothioamide derivatives as novel RXRα antagonists. : Journal of enzyme inhibition and medicinal chemistry. 20201215.